TAKEDA PHARMACEUTICAL CO LTD
TAK·874060205·US·ADR·Healthcare - Drug Manufacturers - Specialty & Generic
TAK (TAKEDA PHARMACEUTICAL CO LTD) is held by 125 institutional investors as of Q1 2026. Largest holders: Capital Research Global Investors ($353.8M), FMR LLC ($131.8M), MORGAN STANLEY ($119.8M). Net institutional sentiment: Bullish. In Q1 2026, 1 member of Congress and 93 funds bought TAK.
125
Holders
(13 Elite)
$1.6B
Total Value
73% (127)
Consensus
93 buying - 34 selling
13F: Insider & Congress:
Who's Trading
InsiderWPWeber Christophe PierreVest 79K shApr 27, 2026
InsiderPSPlump Andrew StewartVest 212K shApr 27, 2026
InsiderKSKim Julie So-YoungVest 105K shApr 27, 2026
InsiderWPWeber Christophe PierreVest 165K shApr 27, 2026
InsiderPRPlatford Giles RichardVest 72K shApr 27, 2026
InsiderBMBitetti Teresa MarieVest 65K shApr 27, 2026
InsiderDRDuprey Lauren RusckowskiVest 60K shApr 27, 2026
InsiderPMPignagnoli Agosti MarcelloVest 28K shApr 27, 2026
InsiderRGRicci GabrieleVest 35K shApr 27, 2026
Top Holders
Showing 1-20 of 135
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer